Viewing nowTelrod Tablet 80mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
(Co., Ltd.) Arise Pharmaceutical

MFDS item code 201907169 · Approved 2019.10.10 · Insurance code 058200360
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
This medication is used to effectively control blood pressure in patients with essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and death due to cardiovascular disease in high-risk patients aged 55 and older with a high risk of developing cardiovascular disease. It is especially suitable as an alternative therapy when ACE inhibitors cannot be used. This medication plays an important role in blood pressure management and the prevention of cardiovascular complications, contributing to the overall improvement of the patient's health. Therefore, it is used for essential hypertension and the reduction of cardiovascular disease risk.
1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally with water at a dose of 80 mg once daily, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication may cause serious harm to the fetus and newborn, especially during pregnancy, and should be discontinued immediately if pregnancy is confirmed. Patients with a known allergy to this medication or its ingredients, those who are pregnant or breastfeeding, patients with severe liver disease or biliary obstruction, patients with hereditary angioedema, and those with diabetes or severe renal impairment should not use this medication. Elderly patients, patients with high potassium levels, patients with mild to moderate liver disease, patients with specific heart diseases, patients with gastrointestinal diseases, patients with renal vascular hypertension, and patients with severe renal impairment should use this medication with caution and have their conditions monitored continuously. Various side effects such as headache, dizziness, cough, indigestion, muscle pain, low blood pressure, and others may occur while taking this medication, so if abnormal symptoms arise, consult a healthcare professional immediately. Especially if swelling occurs in the face, lips, or throat, discontinue use immediately and seek emergency treatment. Regular blood tests should be performed due to the risk of elevated potassium levels, and renal function should also be monitored periodically. If symptoms of low blood pressure occur, it is important to position the patient lying down and administer fluid treatment if necessary. This medication can cause excessively low blood pressure when taken with other antihypertensive drugs, so interactions with other medications being taken should be carefully verified. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should also avoid it. It is not recommended for children under 18 years, as safety and efficacy have not been established. Elderly patients should carefully monitor their condition while taking this medication to prevent excessively low blood pressure. In the case of overdose, symptoms may include low blood pressure, dizziness, abnormal heart rate, acute renal failure, and immediate medical assistance should be sought. This medication should be kept out of reach of children, and it is advisable to open the sealed packaging just before taking it. Caution should be exercised while driving or operating machinery due to the risk of dizziness or fainting.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air and moisture. Additionally, it is best to store the medication at room temperature, ideally between 1°C and 30°C, without extreme temperature fluctuations.
White oval-shaped tablet
30 tablets/box [10 tablets/Alu-Alu x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
(Co., Ltd.) Arise Pharmaceutical

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.